Hallal David (0001457477)

Mailing Address C/O ALEXION PHARMACEUTICALS, INC 352 KNOTTER DRIVE CHESHIRE CT 06410 Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.) Issuer Filings Transaction Date Type of Owner Seer, Inc. 0001726445 2021-06-17 director Allovir, Inc. Current Name:Kalaris Therapeutics, Inc. 0001754068 2020-07-29 director, 10 percent owner, officer: Chief Executive Officer iTeos Therapeutics, Inc. 0001808865 2020-07-23 director Scholar Rock Holding Corp 0001727196 2018-05-23 director ALEXION PHARMACEUTICALS INC Current Name:ALEXION PHARMACEUTICALS, INC. 0000899866 2013-01-28 officer: EVP. Global Commercial Ops

Items 1 - 80

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition	Transaction Date	Deemed Execution Date	Issuer	Form	Transaction Type	Direct or Indirect Ownership	Number of Securities Transacted	Number of Securities Owned	Line Number	Issuer CIK	Security Name
A	2024-06-27		Scholar Rock Holding Corp	4	A-Award	--D	18000.0000	18000.0000	2	0001727196	Stock Option (Right to Buy)
A	2024-06-27		Scholar Rock Holding Corp	4	A-Award	--D	13500.0000	304095.0000	1	0001727196	Common Stock
A	2024-06-12		Seer, Inc.	4	A-Award	--D	58178.0000	355128.0000	1	0001726445	Class A Common Stock
A	2024-06-11		iTeos Therapeutics, Inc.	4	A-Award	--D	24200.0000	24200.0000	1	0001808865	Stock Option (Right to Buy)
A	2024-06-06		Allovir, Inc.	4	A-Award	--D	35000.0000	2143662.0000	1	0001754068	Common Stock
A	2023-06-21		Scholar Rock Holding Corp	4	A-Award	--D	36000.0000	36000.0000	1	0001727196	Stock Option (Right to Buy)
A	2023-06-14		Seer, Inc.	4	A-Award	--D	34735.0000	34735.0000	2	0001726445	Stock Option (right to buy)
A	2023-06-14		Seer, Inc.	4	A-Award	--D	23443.0000	296950.0000	1	0001726445	Class A Common Stock
A	2023-06-13		iTeos Therapeutics, Inc.	4	A-Award	--D	22383.0000	22383.0000	1	0001808865	Stock Option (Right to Buy)
A	2023-05-11		Allovir, Inc.	4	A-Award	--D	35000.0000	2108662.0000	1	0001754068	Common Stock
D	2022-10-19		Allovir, Inc.	4	S-Sale	--I	600000.0000	138153.0000	1	0001754068	Common Stock
D	2022-09-29		Allovir, Inc.	4	S-Sale	--I	400000.0000	720965.0000	1	0001754068	Common Stock
A	2022-07-28		Allovir, Inc.	4	A-Award	--I	3253796.0000	16674766.0000	1	0001754068	Common Stock
D	2022-07-21		Allovir, Inc.	4	S-Sale	--D	4227.0000	2073662.0000	1	0001754068	Common Stock
A	2022-06-16		Scholar Rock Holding Corp	4	A-Award	--D	14000.0000	14000.0000	1	0001727196	Stock Option (Right to Buy)
A	2022-06-15		Seer, Inc.	4	A-Award	--D	29640.0000	29640.0000	2	0001726445	Stock Option (right to buy)
A	2022-06-15		Seer, Inc.	4	A-Award	--D	9945.0000	273507.0000	1	0001726445	Class A Common Stock
A	2022-06-09		iTeos Therapeutics, Inc.	4	A-Award	--D	17538.0000	17538.0000	13	0001808865	Stock Option (Right to Buy)
D	2022-06-09		iTeos Therapeutics, Inc.	4	M-Exempt	--D	1171.0000	146160.0000	12	0001808865	Stock Option (Right to Buy)
D	2022-06-09		iTeos Therapeutics, Inc.	4	S-Sale	--D	1171.0000	0.0000	8	0001808865	Common Stock
A	2022-06-09		iTeos Therapeutics, Inc.	4	M-Exempt	--D	1171.0000	1171.0000	7	0001808865	Common Stock
D	2022-06-08		iTeos Therapeutics, Inc.	4	M-Exempt	--D	10577.0000	147331.0000	11	0001808865	Stock Option (Right to Buy)
D	2022-06-08		iTeos Therapeutics, Inc.	4	M-Exempt	--D	11899.0000	25140.0000	10	0001808865	Stock Option (Right to Buy)
D	2022-06-08		iTeos Therapeutics, Inc.	4	M-Exempt	--D	5968.0000	157908.0000	9	0001808865	Stock Option (Right to Buy)
D	2022-06-08		iTeos Therapeutics, Inc.	4	S-Sale	--D	10577.0000	0.0000	6	0001808865	Common Stock
A	2022-06-08		iTeos Therapeutics, Inc.	4	M-Exempt	--D	10577.0000	10577.0000	5	0001808865	Common Stock
D	2022-06-08		iTeos Therapeutics, Inc.	4	S-Sale	--D	11899.0000	0.0000	4	0001808865	Common Stock
A	2022-06-08		iTeos Therapeutics, Inc.	4	M-Exempt	--D	11899.0000	11899.0000	3	0001808865	Common Stock
D	2022-06-08		iTeos Therapeutics, Inc.	4	S-Sale	--D	5968.0000	0.0000	2	0001808865	Common Stock
A	2022-06-08		iTeos Therapeutics, Inc.	4	M-Exempt	--D	5968.0000	5968.0000	1	0001808865	Common Stock
D	2022-06-03		Allovir, Inc.	4	S-Sale	--D	65725.0000	2077889.0000	1	0001754068	Common Stock
A	2022-05-26		Scholar Rock Holding Corp	4	A-Award	--D	28000.0000	28000.0000	1	0001727196	Stock Option (Right to Buy)
A	2022-05-17		Allovir, Inc.	4	A-Award	--D	27500.0000	27500.0000	1	0001754068	Stock Option (Right to Buy)
D	2022-04-21		Allovir, Inc.	4	S-Sale	--D	4227.0000	2143614.0000	1	0001754068	Common Stock
D	2022-03-11		Allovir, Inc.	4	S-Sale	--D	25244.0000	2147841.0000	2	0001754068	Common Stock
D	2022-03-10		Allovir, Inc.	4	S-Sale	--D	40481.0000	2173085.0000	1	0001754068	Common Stock
D	2022-01-24		Allovir, Inc.	4	S-Sale	--D	17100.0000	2213566.0000	1	0001754068	Common Stock
D	2021-12-20		iTeos Therapeutics, Inc.	4	M-Exempt	--D	30000.0000	37039.0000	5	0001808865	Stock Option (Right to Buy)
D	2021-12-20		iTeos Therapeutics, Inc.	4	M-Exempt	--D	20000.0000	114682.0000	4	0001808865	Stock Option (Right to Buy)
D	2021-12-20		iTeos Therapeutics, Inc.	4	S-Sale	--D	50000.0000	0.0000	3	0001808865	Common Stock
A	2021-12-20		iTeos Therapeutics, Inc.	4	M-Exempt	--D	30000.0000	50000.0000	2	0001808865	Common Stock
A	2021-12-20		iTeos Therapeutics, Inc.	4	M-Exempt	--D	20000.0000	20000.0000	1	0001808865	Common Stock
A	2021-06-17		Seer, Inc.	4	A-Award	--D	15000.0000	15000.0000	1	0001726445	Stock Option (right to buy)
A	2021-06-17		iTeos Therapeutics, Inc.	4	A-Award	--D	16608.0000	16608.0000	1	0001808865	Stock Option (Right to Buy)
A	2021-05-27		Scholar Rock Holding Corp	4	A-Award	--D	7800.0000	7800.0000	1	0001727196	Stock Option (Right to Buy)
A	2021-05-25		Allovir, Inc.	4	A-Award	--D	22500.0000	22500.0000	1	0001754068	Stock Option (Right to Buy)
A	2021-01-21		Allovir, Inc.	4	A-Award	--D	273000.0000	273000.0000	5	0001754068	Stock Option (Right to Buy)
A	2021-01-21		Allovir, Inc.	4	A-Award	--D	147000.0000	2230666.0000	1	0001754068	Common Stock
A	2020-12-03		Seer, Inc.	4	A-Award	--D	18691.0000	18691.0000	1	0001726445	Stock Option (right to buy)
D	2020-08-03		Allovir, Inc.	4	C-Conversion	--I	1100000.0000	0.0000	7	0001754068	Series A-4 Convertible Preferred Stock
A	2020-08-03		Allovir, Inc.	4	C-Conversion	--I	13420970.0000	13420970.0000	1	0001754068	Common Stock
A	2020-08-03		Allovir, Inc.	4	C-Conversion	--I	156577.0000	1120965.0000	2	0001754068	Common Stock
A	2020-08-03		Allovir, Inc.	4	C-Conversion	--I	738153.0000	738153.0000	3	0001754068	Common Stock
D	2020-08-03		Allovir, Inc.	4	C-Conversion	--I	233333.0000	0.0000	6	0001754068	Series A-4 Convertible Preferred Stock
D	2020-08-03		Allovir, Inc.	4	C-Conversion	--I	20000000.0000	0.0000	5	0001754068	Series A-2 Convertible Preferred Stock
A	2020-07-29		Allovir, Inc.	4	A-Award	--D	1101000.0000	1101000.0000	1	0001754068	Stock Option (Right to Buy)
A	2020-07-23		iTeos Therapeutics, Inc.	4/A	A-Award	--D	16608.0000	0.0000	1	0001808865	Stock Option (Right to Buy)
A	2020-07-23		iTeos Therapeutics, Inc.	4	A-Award	--D	16608.0000	0.0000	1	0001808865	Stock Option (Right to Buy)
A	2020-06-16		Scholar Rock Holding Corp	4	A-Award	--D	7000.0000	7000.0000	2	0001727196	Stock Option (right to buy)
A	2020-06-16		Scholar Rock Holding Corp	4	A-Award	--D	13000.0000	13000.0000	1	0001727196	Stock Option (right to buy)
D	2019-09-18		Scholar Rock Holding Corp	4	G-Gift	--D	2000.0000	290595.0000	1	0001727196	Common Stock
A	2019-05-21		Scholar Rock Holding Corp	4	A-Award	--D	10158.0000	10158.0000	1	0001727196	Stock Option (Right to Buy)
A	2018-06-22		Scholar Rock Holding Corp	4	A-Award	--D	20316.0000	20316.0000	1	0001727196	Stock Option (right to buy)
D	2016-08-08		ALEXION PHARMACEUTICALS INC	4	S-Sale	--D	332.0000	189266.0000	1	0000899866	Common Stock, par value $.0001 per share
D	2016-04-01		ALEXION PHARMACEUTICALS INC	4	S-Sale	--D	34.0000	189598.0000	2	0000899866	Common Stock, par value $.0001 per share
D	2016-04-01		ALEXION PHARMACEUTICALS INC	4	S-Sale	--D	1380.0000	189632.0000	1	0000899866	Common Stock, par value $.0001 per share
D	2016-02-29		ALEXION PHARMACEUTICALS INC	4	S-Sale	--D	14.0000	191012.0000	3	0000899866	Common Stock, par value $.0001 per share
D	2016-02-29		ALEXION PHARMACEUTICALS INC	4	S-Sale	--D	2000.0000	191026.0000	2	0000899866	Common Stock, par value $.0001 per share
A	2016-02-26		ALEXION PHARMACEUTICALS INC	4	A-Award	--D	131000.0000	131000.0000	4	0000899866	Option to Purchase Common Stock
A	2016-02-26		ALEXION PHARMACEUTICALS INC	4	A-Award	--D	20000.0000	193026.0000	1	0000899866	Common Stock, par value $.0001 per share
D	2016-02-08		ALEXION PHARMACEUTICALS INC	4	S-Sale	--D	3492.0000	173026.0000	12	0000899866	Common Stock, par value $.0001 per share
D	2016-02-08		ALEXION PHARMACEUTICALS INC	4	S-Sale	--D	117.0000	176518.0000	11	0000899866	Common Stock, par value $.0001 per share
D	2016-02-08		ALEXION PHARMACEUTICALS INC	4	S-Sale	--D	337.0000	176635.0000	10	0000899866	Common Stock, par value $.0001 per share
D	2016-02-05		ALEXION PHARMACEUTICALS INC	4	S-Sale	--D	400.0000	183184.0000	5	0000899866	Common Stock, par value $.0001 per share
D	2016-02-05		ALEXION PHARMACEUTICALS INC	4	S-Sale	--D	110.0000	183584.0000	4	0000899866	Common Stock, par value $.0001 per share
D	2016-02-05		ALEXION PHARMACEUTICALS INC	4	S-Sale	--D	300.0000	182884.0000	6	0000899866	Common Stock, par value $.0001 per share
D	2016-02-05		ALEXION PHARMACEUTICALS INC	4	S-Sale	--D	3710.0000	178462.0000	8	0000899866	Common Stock, par value $.0001 per share
D	2016-02-05		ALEXION PHARMACEUTICALS INC	4	S-Sale	--D	712.0000	182172.0000	7	0000899866	Common Stock, par value $.0001 per share
D	2016-02-05		ALEXION PHARMACEUTICALS INC	4	S-Sale	--D	1490.0000	176972.0000	9	0000899866	Common Stock, par value $.0001 per share
D	2016-02-04		ALEXION PHARMACEUTICALS INC	4	S-Sale	--D	10.0000	142558.0000	2	0000899866	Common Stock, par value $.0001 per share

http://www.sec.gov/cgi-bin/own-disp

---